The FDA on Monday approved the first new drug to treat Alzheimer’s disease in nearly two decades. Federal health officials said it may help slow the brain-destroying disease’s progression, but the approval goes against the agency’s independent advisers who said the treatment wasn’t effective in clinical trials. Pam Belluck, health reporter for The New York Times, joins Amna Nawaz to discuss.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts